Nanocomposite electrocatalysts (M/ZrO2-NG; M: Fe, Co, Fe-Co) consisting of transition metals deposited on zirconium oxide/N-doped graphene were synthesized in the present study. These electrocatalysts were found to be efficient for the oxygen reduction reaction (ORR). A one-step low-temperature solvothermal method was utilized to synthesize nitrogen-doped graphene (NG), which displayed a certain level of alkaline media ORR activity. To enhance both the activity and stability of ORR, ZrO2 was hybridized with NG. Next, a hydrothermal synthesis method was employed to deposit iron and cobalt nanoparticles on ZrO2-NG. The as-prepared electrocatalysts were characterized using various physicochemical, morphological, and electrochemical analyses. FESEM, EDS mapping, HRTEM, XPS, XRD, and FTIR analyses were used to characterize the synthesized NG, ZrO2-NG, and M/ZrO2-NG electrocatalysts. The characterization results indicated that transition metal nanoparticles were homogeneously dispersed on the ZrO2-NG nanocomposite. The electrochemical analysis revealed that the Fe-Co/ZrO2-NG electrocatalyst had the optimal performance with Eonset and E1/2 of 0.872 ± 0.010 and 0.782 ± 0.006 VRHE, respectively, which was comparable to the commercial Pt/C (Eonset = 0.942 ± 0.013 and E1/2 = 0.852 ± 0.009 VRHE). Additionally, chronoamperometric results indicated that the Fe-Co/ZrO2-NG electrocatalyst exhibited better stability (92 % maintenance of its initial current density) than the commercial Pt/C. The high activity and good stability of the optimized nanocomposite electrocatalyst were attributed to the synergistic effect between the zirconium oxide nanoparticles and nitrogen-doped graphene, in addition to the presence of Fe and Co nanoparticles.
No takes yet. Share an insight, caveat, or question.
Rowshanzamir et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: